Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
LUMOS PHARMA, INC. (NLNK)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/03/2023 |
4
| McKew John C. (Chief Scientific Officer) has filed a Form 4 on LUMOS PHARMA, INC.|
Txns:
| Paid exercise price by delivering 1,593 shares
@ $3.28, valued at
$5.2k
Sold 3,407 shares
@ $3.205, valued at
$10.9k
|
|
| 08/03/2023 |
4
| Lawley Lori D (CFO) has filed a Form 4 on LUMOS PHARMA, INC.|
Txns:
| Paid exercise price by delivering 229 shares
@ $3.28, valued at
$751.1 |
|
| 05/12/2023 |
4
| Zoth Lota S. (Director) has filed a Form 4 on LUMOS PHARMA, INC.|
Txns:
| Granted 3,345 options to buy
@ $3.42, valued at
$11.4k
|
|
| 05/12/2023 |
4
| van Es-Johansson An (Director) has filed a Form 4 on LUMOS PHARMA, INC.|
Txns:
| Granted 3,345 options to buy
@ $3.42, valued at
$11.4k
|
|
| 05/12/2023 |
4
| Raffin Thomas A. (Director) has filed a Form 4 on LUMOS PHARMA, INC.|
Txns:
| Granted 3,345 options to buy
@ $3.42, valued at
$11.4k
|
|
| 05/12/2023 |
4
| McCracken Joseph S (Director) has filed a Form 4 on LUMOS PHARMA, INC.|
Txns:
| Granted 3,345 options to buy
@ $3.42, valued at
$11.4k
|
|
| 05/12/2023 |
4
| LALANDE KEVIN M. (Director) has filed a Form 4 on LUMOS PHARMA, INC.|
Txns:
| Granted 3,345 options to buy
@ $3.42, valued at
$11.4k
|
|
| 05/12/2023 |
4
| JOHNSON CHAD ALLEN (Director) has filed a Form 4 on LUMOS PHARMA, INC.|
Txns:
| Granted 3,345 options to buy
@ $3.42, valued at
$11.4k
|
|
| 04/04/2023 |
4
| POWERS BRADLEY J (General Counsel) has filed a Form 4 on LUMOS PHARMA, INC.|
Txns:
| Paid exercise price by delivering 342 shares
@ $3.31, valued at
$1.1k
|
|
| 04/04/2023 |
4
| McKew John C. (Chief Scientific Officer) has filed a Form 4 on LUMOS PHARMA, INC.|
Txns:
| Paid exercise price by delivering 1,036 shares
@ $3.31, valued at
$3.4k
Sold 2,214 shares
@ $3.27, valued at
$7.2k
|
|
| 04/04/2023 |
4
| Lawley Lori D (CFO) has filed a Form 4 on LUMOS PHARMA, INC.|
Txns:
| Paid exercise price by delivering 274 shares
@ $3.31, valued at
$906.9 |
|
| 04/04/2023 |
4
| Hawkins Richard J (CEO) has filed a Form 4 on LUMOS PHARMA, INC.|
Txns:
| Paid exercise price by delivering 1,522 shares
@ $3.31, valued at
$5k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2022 |
4
| McCracken Joseph S (Director) has filed a Form 4 on LUMOS PHARMA, INC.|
Txns:
| Bought 4,000 shares
@ $5.03, valued at
$20.1k
|
|
| 09/23/2022 |
4
| Hawkins Richard J (CEO) has filed a Form 4 on LUMOS PHARMA, INC.|
Txns:
| Bought 2,214 shares
@ $8.84, valued at
$19.6k
Bought 208 shares
@ $8.8, valued at
$1.8k
|
|
| 09/21/2022 |
4
| Hawkins Richard J (CEO) has filed a Form 4 on LUMOS PHARMA, INC.|
Txns:
| Bought 541 shares
@ $8.65, valued at
$4.7k
Bought 1,506 shares
@ $8.75, valued at
$13.2k
|
|
| 09/06/2022 |
4
| Karpf David B (Chief Medical Officer) has filed a Form 4 on LUMOS PHARMA, INC.|
Txns:
| Paid exercise price by delivering 570 shares
@ $8.53, valued at
$4.9k
|
|
| 08/26/2022 |
4
| Raffin Thomas A. (Director) has filed a Form 4 on LUMOS PHARMA, INC.|
Txns:
| Bought 1,150 shares
@ $8.46, valued at
$9.7k
|
|
| 08/26/2022 |
4
| McCracken Joseph S (Director) has filed a Form 4 on LUMOS PHARMA, INC.|
Txns:
| Bought 3,170 shares
@ $8.6, valued at
$27.3k
|
|
| 08/03/2022 |
4
| McKew John C. (Chief Scientific Officer) has filed a Form 4 on LUMOS PHARMA, INC.|
Txns:
| Paid exercise price by delivering 1,593 shares
@ $8.17, valued at
$13k
Sold 3,407 shares
@ $8.11, valued at
$27.6k
|
|
| 08/03/2022 |
4
| Lawley Lori D (CFO) has filed a Form 4 on LUMOS PHARMA, INC.|
Txns:
| Paid exercise price by delivering 229 shares
@ $8.17, valued at
$1.9k
|
|
| 06/07/2022 |
4
| McKew John C. (Chief Scientific Officer) has filed a Form 4 on LUMOS PHARMA, INC.|
Txns:
| Sold 169 shares
@ $7.62, valued at
$1.3k
|
|
| 05/09/2022 |
4
| Zoth Lota S. (Director) has filed a Form 4 on LUMOS PHARMA, INC.|
Txns:
| Granted 3,431 options to buy
@ $8.18, valued at
$28.1k
|
|
| 05/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/09/2022 |
4
| Raffin Thomas A. (Director) has filed a Form 4 on LUMOS PHARMA, INC.|
Txns:
| Granted 3,431 options to buy
@ $8.18, valued at
$28.1k
|
|
| 05/09/2022 |
4
| McCracken Joseph S (Director) has filed a Form 4 on LUMOS PHARMA, INC.|
Txns:
| Granted 3,431 options to buy
@ $8.18, valued at
$28.1k
|
|
| 05/09/2022 |
4
| LALANDE KEVIN M. (Director) has filed a Form 4 on LUMOS PHARMA, INC.|
Txns:
| Granted 3,431 options to buy
@ $8.18, valued at
$28.1k
|
|
| 05/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2022 |
4
| POWERS BRADLEY J (General Counsel) has filed a Form 4 on LUMOS PHARMA, INC.|
Txns:
| Paid exercise price by delivering 342 shares
@ $9.23, valued at
$3.2k
|
|
|
|
|